Røder, M. A., Brasso, K., Christensen, I. J., Johansen, J., Langkilde, N. C., Hvarness, H., Carlsson, S., Jakobsen, H., Borre, M. & Iversen, P. (2013). Survival after radical prostatectomy for clinically localised prostate cancer: a population-based study. B J U International (Print). https://doi.org/10.1111/bju.12065

Christensen, J. S., Asklund, C., Skakkebæk, N. E., Jørgensen, N., Andersen, H. R., Jørgensen, T. M., Olsen, L. H., Høyer, A. P., Moesgaard, J., Thorup, J. M. & Jensen, T. K. (2013). Association between organic dietary choice during pregnancy and hypospadias in offspring: A study of mothers of 306 boys operated for hypospadias. The Journal of Urology, 189(3), 1077-1082. https://doi.org/10.1016/j.juro.2012.09.116

Wagenlehner, F. M. E., van Oostrum, E., Tenke, P., Tandogdu, Z., Çek, M., Grabe, M., Wullt, B., Pickard, R., Naber, K. G., Pilatz, A., Weidner, W., Johansen, T. E. B. & GPIU investigators (2013). Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. European Urology, 63(3), 521-7. https://doi.org/10.1016/j.eururo.2012.06.003

Wagenlehner, F., van Oostrum, E., Tenke, P., Tandogdu, Z., Cek, M., Grabe, M., Wullt, B., Pickard, R., Naber, K. G., Pilatz, A., Weidner, W. & Johansen, T. E. B. (2013). Reply from Authors re.: Riccardo Bartoletti, Tommaso Cai.Prostate Biopsies Should Be Performed According to a Standard of Care. European Urology, 63(3), 529-30. Article 63, 3. https://doi.org/10.1016/j.eururo.2012.07.037

Jespersen, C. G., Nørgaard, M. & Borre, M. (2013). Androgen-deprivation Therapy in Treatment of Prostate Cancer and Risk of Myocardial Infarction and Stroke: A Nationwide Danish Population-based Cohort Study. European Urology (Italian Edition). https://doi.org/10.1016/j.eururo.2013.02.002

Fristrup, N., Birkenkamp-Demtröder, K., Reinert, T., Sanchez-Carbayo, M., Segersten, U., Malmström, P.-U., Palou, J., Alvarez-Múgica, M., Pan, C.-C., Ulhøi, B. P., Borre, M., Ørntoft, T. F. & Andersen, L. D. (2013). Multicenter validation of Cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle invasive bladder cancer. American Journal of Pathology, 182(2), 339-349. https://doi.org/10.1016/j.ajpath.2012.10.017

Sørensen, K. D., Abildgaard, M. O., Haldrup, C., Ulhøi, B. P., Kristensen, H., Strand, S. H., Parker, C., Høyer, S., Borre, M. & Ørntoft, T. F. (2013). Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer. B J C, (108), 420-428. https://doi.org/10.1038/bjc.2012.549

Birkenkamp-Demtröder, K., Mansilla, F., Andersen, L. D., Thorsen, K., Fristrup, N., Brems-Eskildsen, A. S., Madsen, P. P., Sørensen, K. D., Borre, M. & Ørntoft, T. F. (2013). TOX3 (TNRC9) overexpression in bladder cancer cells decreases cellular proliferation and triggers an interferon-like response. Journal of Molecular Biomarkers & Diagnosis, 4(1), 1-11. https://doi.org/10.4172/2155-9929.1000140

Schepeler, T., Lamy, P., Hvidberg, V., Laurberg, J. R., Fristrup, N., Reinert, T., Bartkova, J., Tropia, L., Bartek, J., Halazonetis, T. D., Pan, C.-C., Borre, M., Andersen, L. D. & Orntoft, T. F. (2013). A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response. Oncogene, 32, 3577-3586. https://doi.org/10.1038/onc.2012.381

Amin Al Olama, A., Kote-Jarai, Z., Schumacher, F. R., Wiklund, F., Berndt, S. I., Benlloch, S., Giles, G. G., Severi, G., Neal, D. E., Hamdy, F. C., Donovan, J. L., Hunter, D. J., Henderson, B. E., Thun, M. J., Gaziano, M., Giovannucci, E. L., Siddiq, A., Travis, R. C., Cox, D. G. ... The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology (2013). A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Human Molecular Genetics. https://doi.org/10.1093/hmg/dds425

Kingo, P. S., Ryhammer, A. M. & Fuglsig, S. (2013). Clinical experience with the Swiss LithoClast® Master in treatment of bladder calculi. Journal of Endourology. https://doi.org/10.1089/end.2011.0512

Rasmussen, M. M., Krogh, K., Clemmensen, D., Bluhme, H., Rawashdeh, Y. F. H. & Christensen, P. (2013). Colorectal transport during defecation in subjects with supraconal spinal cord injury. Spinal Cord, 51(9).

Nguyen-Nielsen, M., Nørgaard, M., Jacobsen, J. B., Borre, M., Thomsen, R. W. & Søgaard, M. (2013). Comorbidity and survival of Danish prostate cancer patients from 2000-2011: a population-based cohort study. Clinical epidemiology, 5(Suppl 1), 47-55. https://doi.org/10.2147/CLEP.S47153

Kingo, P. S. (2013). Creating a network of professional contacts: Danish resident gives high approval mark of Residents day. European Urology Today, European Urology Today(25 (2)), 22-22.

Madsen, M. G., Nørregaard, R., Palmfeldt, J., Olsen, L. H., Frøkiær, J. & Jørgensen, T. M. (2013). Epidermal growth factor and monocyte chemotactic peptide-1: Potential biomarkers of urinary tract obstruction in children with hydronephrosis. Journal of Pediatric Urology, 9(6 (Part A)), 838–845. https://doi.org/10.1016/j.jpurol.2012.11.011

Keller, A. K., Jørgensen, T. M., Vittrup, D. M., Kjerkegaard, U. K., Jespersen, B., Krag, S. R. P., Bibby, B. M. & Stolle, L. B. (2013). Fast Detection of Renal Ischemia in Transplanted Kidneys With Delayed Graft Function-An Experimental Study. Transplantation, 95(2), 275-279. https://doi.org/10.1097/TP.0b013e318276a1c8

Borre, M. (2013). PDE5 inhibitor i behandling af nedre urinvejssymptomer. Lægemagasinet, 18-20.

Cockle-Hearne, J., Charnay-Sonnek, F., Denis, L., Fernandez-Ortega, P., Kav, S., Kelly, D., Leonard, K., Van Muilekom, E., Jensen, B. T. & Faithfull, S. (2013). Supportive care needs of men with prostate cancer: A european survey for the prostate cancer education project (PrEP). European Journal of Oncology Nursing, 14-15. Article vol. 16, suppl.

Kristensen, S. A., Laustsen, S., Kiesbye, B. & Jensen, B. T. (2013). The Urostomy Education Scale: a reliable and valid tool to evaluate urostomy self-care skills among cystectomy patients. Journal of Wound, Ostomy and Continence Nursing, 40(6), 611-7. https://doi.org/10.1097/01.WON.0000436778.39349.12

Jensen, B. T., de Blok, W., Kiesbye, B. & Kristensen, S. A. (2013). Validation of the urostomy education scale: the European experience. Urologic Nursing, 33(5), 219-29.

Borre, M. (2012). Cytoreduktiv prostatakirurgi som alternativ behandling ved avanceret prostatacancer. Ugeskrift for Læger, 174(50), 3154.

Maniecki, M. B., Etzerodt, A., Ulhøi, B. P., Steiniche, T., Borre, M., Andersen, L. D., Orntoft, T. F., Moestrup, S. K. & Møller, H. J. (2012). Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells. International Journal of Cancer, 131(10), 2320-2331. https://doi.org/10.1002/ijc.27506

Jensen, M. S., Snerum, T. M., Olsen, L. H., Thulstrup, A. M., Bonde, J. P., Olsen, J. & Henriksen, T. B. (2012). Accuracy of Cryptorchidism Diagnoses and Corrective Surgical Treatment Registration in the Danish National Patient Registry. Journal of Urology, 188(4), 1324-1329.

Andersen, L. D., Reinert, T., Novoradovsky, A., Zuiverloon, T. C. M., Beukers, W., Zwarthoff, E., Malats, N., Real, F. X., Segersten, U., Malmström, P.-U., Knowles, M., Hurst, C., Sorge, J., Borre, M. & Orntoft, T. F. (2012). Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR. B J C, (107), 1392-1398. https://doi.org/10.1038/bjc.2012.412

Nordentoft, I. K., Birkenkamp-Demtröder, K., Agerbæk, M., Theodorescu, D., Ostenfeld, M. S., Hartmann, A., Borre, M., Ørntoft, T. F. & Andersen, L. D. (2012). miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer. B M C Medical Genomics, 5(40), 1-11. https://doi.org/10.1186/1755-8794-5-40

Pandha, H., Sørensen, K. D., Ørntoft, T. F., Langley, S., Hoyer, S., Borre, M. & Morgan, R. (2012). Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer. B J U International (Print), 110(6 Pt B), E287-92. https://doi.org/10.1111/j.1464-410X.2012.11208.x

Bentzon, D. N., Nyegaard, M., Børglum, A., Ørntoft, T. F., Borre, M. & Dalsgaard Sørensen, K. (2012). Replication of Prostate Cancer Risk Variants in a Danish Case-Control Association Study. Open Journal of Urology, 2(2), 45-54. https://doi.org/10.4236/oju.2012.22009

Abildgaard, M. O., Borre, M., Mørck Mortensen, M., Ulhøi, B. P., Tørring, N., Wild, P., Kristensen, H., Mansilla, F., Ottosen, P. D., Andersen, L. D., Orntoft, T. F. & Dalsgaard Sørensen, K. (2012). Downregulation of ZNF132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis. International Journal of Cancer, 130(4), 885-895. https://doi.org/10.1002/ijc.26097

Villadsen, S. B., Bramsen, J. B., Ostenfeld, M. S., Wiklund, E. D., Fristrup, N., Gao, S., Hansen, T. B., Jensen, T. I., Borre, M., Orntoft, T. F., Dyrskjøt, L. & Kjems, J. (2012). The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer. B J C, 106(2), 366-374. https://doi.org/10.1038/bjc.2011.520

Wang, G., Yuan, W., Kwon, T.-H., Li, Z., Wen, J., Topcu, S. O., Djurhuus, J. C., Nielsen, S. & Frøkiær, J. (2012). Age-related changes in expression in renal AQPs in response to congenital, partial, unilateral ureteral obstruction in rats. Pediatric Nephrology, 27(1), 83-94. https://doi.org/10.1007/s00467-011-1878-x

Cek, M., Tandoğdu, Z., Naber, K., Tenke, P., Wagenlehner, F., van Oostrum, E., Kristensen, B., Johansen, T. E. B. & on behalf of the Global Prevalence Study of Infections in Urology Investigators (2012). Antibiotic Prophylaxis in Urology Departments, 2005-2010. European Urology (Italian Edition). https://doi.org/10.1016/j.eururo.2012.09.038